Department
Department of Physiology
Publications (61) Publications in which a researcher has participated
2024
-
AB067. New drug development for the use of PARP1-E2F1 transcriptional inhibitors in the treatment of glioblastoma
Chinese clinical oncology, Vol. 13, pp. AB067
-
AI is a viable alternative to high throughput screening: a 318-target study
Scientific Reports, Vol. 14, Núm. 1
-
Aggregation-resistant alpha-synuclein tetramers are reduced in the blood of Parkinson’s patients
EMBO Molecular Medicine, Vol. 16, Núm. 7, pp. 1657-1674
-
Antiobesity effects of intestinal gluconeogenesis are mediated by the brown adipose tissue sympathetic nervous system
Obesity, Vol. 32, Núm. 4, pp. 710-722
-
Antioxidant micropeptins from a Microcoleus autumnalis-dominated benthic cyanobacterial mat from Western Ireland
Phytochemistry, Vol. 223
-
Application of a multi-toxin detect method to analyze mycotoxins occurrence in plant-based beverages
Food Chemistry, Vol. 434
-
Association between endocrine and neuropsychological endophenotypes and gambling disorder severity
Addictive Behaviors, Vol. 153
-
Bilateral Uveal Melanoma: An Insight into Genetic Predisposition in Four New Unrelated Patients and Review of Published Cases
Journal of Clinical Medicine, Vol. 13, Núm. 11
-
Bioavailability profiling shows differences in OA, DTX1 and DTX2 toxins that justify their toxicity
Chemosphere, Vol. 366
-
Biodistribution and pharmacokinetics of [89Zr]-anti-VEGF mAbs using PET in glioblastoma rat models
International Journal of Pharmaceutics, Vol. 652
-
Ceramides in the central control of metabolism
Trends in Endocrinology and Metabolism
-
Cluster analysis in gambling disorder based on sociodemographic, neuropsychological, and neuroendocrine features regulating energy homeostasis
Comprehensive Psychiatry, Vol. 128
-
Correction to: AI is a viable alternative to high throughput screening: a 318-target study (Scientific Reports, (2024), 14, 1, (7526), 10.1038/s41598-024-54655-z)
Scientific Reports
-
Correction to: Camrelizumab-based induction chemoimmunotherapy in locally advanced stage hypopharyngeal carcinoma: phase II clinical trial (Nature Communications, (2024), 15, 1, (5251), 10.1038/s41467-024-49121-3)
Nature Communications
-
Correction to: Seeing through the fog: a neuroendocrine explanation for post-COVID cognitive deficits (Nature Reviews Endocrinology, (2024), 20, 4, (189-190), 10.1038/s41574-024-00955-3)
Nature Reviews Endocrinology
-
Correction to: dsRNAi-mediated silencing of PIAS2beta specifically kills anaplastic carcinomas by mitotic catastrophe (Nature Communications, (2024), 15, 1, (3736), 10.1038/s41467-024-47751-1)
Nature Communications
-
Cortical actions of thyroid hormone: An exploration and metabolism crossroad
Cell metabolism, Vol. 36, Núm. 10, pp. 2170-2172
-
Dual and Triple Incretin-Based Co-agonists: Novel Therapeutics for Obesity and Diabetes
DIABETES THERAPY, Vol. 15, Núm. 5, pp. 1069-1084
-
Enniatins A1 and B1 Modulate Calcium Flux through Alternative Pathways beyond Mitochondria
Journal of Agricultural and Food Chemistry, Vol. 72, Núm. 26, pp. 14975-14983
-
Estrogen receptor-α signaling in tanycytes lies at the crossroads of fertility and metabolism
Metabolism: Clinical and Experimental, Vol. 158